about
Leptin therapy in insulin-deficient type I diabetesNarrative review: the role of leptin in human physiology: emerging clinical applicationsLeptin at 14 y of age: an ongoing storyLeptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studiesRevisiting leptin's role in obesity and weight lossAdverse metabolic and cardiovascular consequences of circadian misalignmentRole of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a reviewObesity and cancer, a case for insulin signalingNew advances in the treatment of generalized lipodystrophy: role of metreleptinRole of leptin resistance in the development of obesity in older patientsLeptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individualsPhysiology of leptin: energy homeostasis, neuroendocrine function and metabolismAdipokines - removing road blocks to obesity and diabetes therapyAdipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokinesNeural control of energy balance: translating circuits to therapiesMetabolic Adaptation in Obesity and Type II Diabetes: Myokines, Adipokines and HepatokinesNutrition, insulin resistance and dysfunctional adipose tissue determine the different components of metabolic syndromeLeptin applications in 2015: what have we learned about leptin and obesity?Treatment of metabolic syndromeLeptin induces nitric oxide-mediated inhibition of lipolysis and glyceroneogenesis in rat white adipose tissueAdipocytes as regulators of energy balance and glucose homeostasisAdipokines in inflammation and metabolic diseaseGut-Brain Cross-Talk in Metabolic Control.Adipocytokines in obesity and metabolic disease.Tackling obesity: new therapeutic agents for assisted weight loss.Hyperleptinemia prevents lipotoxic cardiomyopathy in acyl CoA synthase transgenic mice.Central leptin receptor action and resistance in obesity.Inflammation and adipose tissue macrophages in lipodystrophic mice.Leptin revisited: its mechanism of action and potential for treating diabetes.The role of leptin in glucose homeostasis.Obesity as an effect modifier of the association between leptin and diabetic kidney disease.Leptin and soluble leptin receptor levels in plasma and risk of type 2 diabetes in U.S. women: a prospective study.Comparison of the Effect of Acupressure and Pilates-Based Exercises on Sleep Quality of Postmenopausal Women: A Randomized Controlled Trial.Adipokine profile and urinary albumin excretion in isolated growth hormone deficiencyLeptin/Adiponectin Ratios Using Either Total Or High-Molecular-Weight Adiponectin as Biomarkers of Systemic Insulin Sensitivity in Normoglycemic WomenPancreatic fat accumulation, fibrosis, and acinar cell injury in the Zucker diabetic fatty rat fed a chronic high-fat diet.Adipokines, hormones related to body composition, and insulin resistance in HIV fat redistribution syndrome.Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes.Leptin deficiency: clinical implications and opportunities for therapeutic interventions.Independent circadian and sleep/wake regulation of adipokines and glucose in humans.
P2860
Q24620780-9051F083-49C1-4C8D-8FD2-228FBBAFAD41Q24634811-5D2AE2EE-3D1B-462D-A53D-5DDE74A13D3EQ24644972-6DB39D5A-CD6D-4611-8346-B2B78CB390BEQ24650977-789E2511-3001-4151-A2A4-C0A1A90AB9B1Q24653878-1DB5AF84-3587-4AEF-8EAC-7A11B0DAD1FEQ24656239-DCEB0829-CE70-498D-A183-CA39B011E451Q24801508-0A8A8D6F-08B7-40D3-B7FE-24843423C17EQ26771452-54E4F256-ECD1-4EFC-9452-1EF5E4287AE5Q26781946-04CDF6FD-913F-42DB-AD6D-57F34A454420Q26824127-C92AAE75-F6B0-40DB-AD3D-1832C3BFB0A8Q26859118-DC51FB7C-73EA-45D2-878A-FAE5F298D474Q26864148-6155A8B5-FFE2-4B0A-A092-0D8F0D54C97BQ26995825-F5513DAB-B533-4D71-810B-C7A7107D26F4Q27001148-86C4F79F-1E87-45BD-89C4-E9306A6F5561Q27005992-A72BD331-6DDC-439F-9928-119E69C26014Q28066564-B805DB96-B444-4228-A7D6-6C5A99852436Q28079661-C07674C1-30CB-408E-9096-2273508D1819Q28087233-F4092A89-10F8-4334-8B94-97F867EE8095Q28168652-B2E63468-9FA8-4DEA-B5BB-EEB694B1D671Q28574330-ADC57A72-4636-4076-8AAD-01413334BE4FQ29619448-7C55B7B2-9E0C-4C06-8A65-444C3DCB415DQ29620456-E7239AC8-75AC-47AE-9F4D-042C3F9A5509Q30235568-66EA5132-0ADE-4B88-86BA-2CAFF7A55AF1Q30357655-D50E3D0B-A53F-413F-9D9D-7563DABA32B7Q30401145-CEF6D08D-0B86-43CE-AD96-085044F3FCDAQ33206447-5C1B143A-DAD8-4FD1-9338-3DEEE62AB25FQ33557577-7A275D1E-CFCA-4F0A-83F8-C80A4C1D7DB2Q33591836-B1643C99-93B2-40AB-BDEF-47195114A378Q33602487-FE6363E8-5335-4984-B539-6EEE7B44B278Q33609782-2FFD98CA-108F-4712-AF2E-0C6807FD7E03Q33622272-EC25AC92-EB81-45A6-A8EC-C8FA3BA74A1CQ33688663-1F198695-713E-4444-B90B-9A775F195ADBQ33723085-F295FC36-533C-4E9F-908C-3E60249B8A05Q33736161-FB5004F1-38CE-4188-9A9C-DC7102134487Q33775646-5403F755-FF7F-4779-AAD8-DE272AD7484EQ33825167-389F98D5-A72A-428F-9DCE-D1D31776687EQ33836736-35950FE8-FDE9-438B-AFFD-E89533BCA2F8Q33846858-48E75253-EE39-4EFE-9358-F38FD97399D2Q33883294-5A7C4256-FB14-4AC4-997A-622E39E40900Q33913905-0C59CD45-2D6F-47C3-92FD-EDF317D71DEF
P2860
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Leptin-replacement therapy for lipodystrophy.
@en
Leptin-replacement therapy for lipodystrophy.
@nl
type
label
Leptin-replacement therapy for lipodystrophy.
@en
Leptin-replacement therapy for lipodystrophy.
@nl
prefLabel
Leptin-replacement therapy for lipodystrophy.
@en
Leptin-replacement therapy for lipodystrophy.
@nl
P2093
P356
P1476
Leptin-replacement therapy for lipodystrophy
@en
P2093
Abhimanyu Garg
Ahalya Premkumar
Alex M DePaoli
Alexa Andewelt
Anthony J Wagner
Elaine Ruiz
Peter Snell
Phillip Gorden
Simeon I Taylor
Vinaya Simha
P304
P356
10.1056/NEJMOA012437
P407
P577
2002-02-01T00:00:00Z